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Abstract
Background: Pseudomonas aeruginosa establishes life-long chronic airway infections in cystic fibrosis (CF) patients.
As the disease progresses, P. aeruginosa pathoadaptive variants are distinguished from the initially acquired strain.
However, the genetic basis and the biology of host-bacteria interactions leading to a persistent lifestyle of P.
aeruginosa are not understood. As a model system to study long term and persistent CF infections, the P.
aeruginosa RP73, isolated 16.9 years after the onset of airways colonization from a CF patient, was investigated.
Comparisons with strains RP1, isolated at the onset of the colonization, and clonal RP45, isolated 7 years before
RP73 were carried out to better characterize genomic evolution of P. aeruginosa in the context of CF pathogenicity.
Results: Virulence assessments in disease animal model, genome sequencing and comparative genomics analysis
were performed for clinical RP73, RP45, RP1 and prototype strains. In murine model, RP73 showed lower lethality
and a remarkable capability of long-term persistence in chronic airways infection when compared to other strains.
Pathological analysis of murine lungs confirmed advanced chronic pulmonary disease, inflammation and mucus
secretory cells hyperplasia. Genomic analysis predicted twelve genomic islands in the RP73 genome, some of which
distinguished RP73 from other prototype strains and corresponded to regions of genome plasticity. Further,
comparative genomic analyses with sequential RP isolates showed signatures of pathoadaptive mutations in
virulence factors potentially linked to the development of chronic infections in CF.
Conclusions: The genome plasticity of P. aeruginosa particularly in the RP73 strain strongly indicated that these
alterations may form the genetic basis defining host-bacteria interactions leading to a persistent lifestyle in human
lungs.
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Background
The opportunistic pathogen Pseudomonas aeruginosa
has broad capabilities to thrive in diverse ecological
niches and to establish serious human infections [1].
Poor clinical outcome of P. aeruginosa-associated infec-
tion was described in immunocompromised patients and
those in intensive care units, connected to mechanical
ventilation or other invasive devices. P. aeruginosa is
also the leading cause of chronic lung infections and
death in patients with cystic fibrosis (CF), as well as a
frequent cause of exacerbations in individuals with
advanced chronic obstructive pulmonary disease
(COPD) [2].
The genetic basis of P. aeruginosa leading to acute or
chronic infection is not yet understood [3]. Genome se-
quencing projects are underway with the aim of provid-
ing new data to dissect the molecular basis of P.
aeruginosa infections. Seventeen completely sequenced
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and assembled genomes are currently available and draft
genomes exist for 561 additional genomes. The genome
size of P. aeruginosa is larger than those of most se-
quenced bacteria and varies between 5.2 and 7 Mbp,
with ~5500 ORFs [4]. A significant number (8,4 %) of P.
aeruginosa genes are predicted to be involved in regula-
tion, which at the time of publication was the largest
fraction of regulators among sequenced bacterial ge-
nomes. Irrespective of their origin, P. aeruginosa isolates
share a remarkable amount of similarity in their genome
content and in virulence traits (core genome). The ex-
tent of divergence between strains is determined by
extra-chromosomal elements like plasmids or blocks of
DNA inserted into the chromosome at various loci [5].
These genetic features are likely to be acquired by hori-
zontal gene transfer from different sources including
other species or genera and can be present in subgroups
of the P. aeruginosa population but may also be unique
to single strains, accounting for most of intra- and inter-
clonal P. aeruginosa genome diversity. These strain-
specific segments of the genome are not scattered
randomly through the core genome; rather, they tend to
be clustered in certain loci, referred to as regions of gen-
ome plasticity (RGPs) [6]. The genetic sequences occu-
pying many RGPs are often referred to as genomic
islands (GIs) and islets. Therefore, the P. aeruginosa
chromosome presents a picture of a mosaic, consisting
of a conserved core component, interrupted in each
strain by the inserted parts of the accessory genome.
Genetic elements within the accessory genome may en-
code properties that contribute to niche-specific adapta-
tion of the particular strains that harbor them.
Furthermore, mutations of single nucleotides also con-
fer specific P. aeruginosa phenotypes that are advanta-
geous under certain conditions [7–10]. Long-term
colonization of the CF host is maintained by P. aerugi-
nosa pathoadaptive lineages, which are clonal with the
initially acquired strain and carry phenotypic variants.
Pathoadaptive mutations are frequent in virulence genes,
essential for acute infection but no longer compatible
with the novel lifestyle of the P. aeruginosa in CF air-
ways. However, little is known about the genetic basis
and the biology of host-bacteria interactions leading to a
persistent lifestyle of P. aeruginosa.
To define the genetic basis of P. aeruginosa persistent
lifestyle, longitudinal isolates from CF patient were se-
lected. In particular, P. aeruginosa RP73 was isolated
after long-term chronic infection and compared with the
preceding RP1 and clonal RP45, as well as prototype
PAO1 and PA14 strains. When murine model of chronic
lung infection was used, RP73 showed a marked persist-
ent lifestyle. Thus, genome sequencing and comparative
genomics analysis were carried out. Our results show
the links between genomic properties and pathogenic
potential of RP73 that may define the basis of long-term
chronic infection by P. aeruginosa. The significance of
these results is discussed in the context of understanding
disease pathogenesis.
Results and discussion
Chronic colonization of a CF patient’s airways with the P.
aeruginosa RP isolates
CF was suspected in the exocrine-insufficient patient
index case RP (CFTR genotype: F508del/R1162X) by a
positive meconium test at birth and was confirmed by
pathological sweat tests at the age of 4 months. The RP
patient’s airways became colonized with P. aeruginosa by
the age of 7 years (Fig. 1). The CF clinic in Hannover
has collected sequential isolates from this patient since
the onset of colonization for up to 28 years [11]. The pa-
tient was chronically carrying P. aeruginosa isolates of
clone type OC2E, for the first eleven years. During this
time period strains of the clone type OC4A were sporad-
ically isolated, but thereafter OC4A has become the
dominant clone type until today. The RP patient re-
ceived one to four annual 2-week courses of intravenous
(iv) antipseudomonal chemotherapy since onset of
colonization and was administered aerosolized colistin
on a daily basis during the last 17 years. The last clone
type OC2E strain was isolated from the patient’s sputum
four months after the start of colistin inhalation. The pa-
tient’s clinical status remained stable during the 28 years
of chronic airway infection. Lung function parameters
fluctuated between 70 and 90 % predicted for forced
vital capacity (FVC) and 60–80 % forced expiratory vol-
ume (FEV1) during the last 20 years with no tendency to
irreversible decline.
In this study three P. aeruginosa isolates from RP
patient were selected for genetic and biological
characterization. RP1 was the first P. aeruginosa isolate
and belongs to clone type OC2E, while RP45 and RP73,
isolated after 10 and 16.9 years from the onset of
colonization, belong to clone type OC4A (Additional file
1 and Cramer et al. [12]). Thus, RP73 P. aeruginosa iso-
late was able to establish long-term infection replacing
the initially RP1 acquired isolate and likely adapting
within CF airways respect to RP45.
Pathogenicity of P. aeruginosa RP isolates in murine
model of airways infection
To translate data from CF patients into disease models,
P. aeruginosa clinical isolates RP1, RP45 and RP73 were
tested in the agar beads mouse model of chronic airways
infection in comparison to prototype PAO1 and PA14
strains [13, 14]. Bacteria embedded in the immobilizing
agents appear to grow in the microaerobic/anaerobic
conditions in form of microcolonies, similarly to the
growth in the mucus of patients with CF [15, 16]. RP1
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isolate, as well as prototype PA14 strain, caused death in
all mice (100 %) within the first three days of P. aerugi-
nosa infection (Fig. 2 and Additional file 2). Lower inci-
dence of mortality (50 %) was recorded after infection
with RP45 strain, while RP73 were not lethal (0 %).
Thus, despite their clonality, RP45 and RP73 were sig-
nificantly different in the risk of death. As previously re-
ported, prototype PAO1 showed 24 % of acute mortality
[17]. Next, the capacity to establish chronic infection in
the surviving mice was assessed at 14 days. Nearly all
Fig. 1 P. aeruginosa sequential isolates from patient RP. Two clone types (OC2E and OC4A) of P. aeruginosa strains were isolated from patient RP who
is heterozygous for F508del and R1162X mutations in the CFTR gene. OC2E was isolated at the onset of chronic colonization for the first eleven years.
Thereafter OC4A became the dominant clone. Strain RP1 belongs to the clone type OC2E and was the first P .aeruginosa strains isolated. Strains RP45
and RP7 belong to the clone type OC4A and were isolated after 10 and 16.9 years respectively after the onset of chronic colonization of the patient’s
airways with P. aeruginosa (Additional file 1 and Cramer et al. [12]). Lung function parameters at the time of P. aeruginosa isolation are indicated
Fig. 2 Virulence of P. aeruginosa RP isolates in comparison with prototype strains in murine model. C57Bl/6NCrlBR mice were infected with 1-
2*106 CFU/lung P. aeruginosa RP1, RP45, RP73, PAO1 and PA14 strains embedded in agar beads. Mortality induced by bacteremia (black) and survival
(light gray) was evaluated on challenged mice. Clearance (white) and capacity to establish chronic infection (dark gray) were determined on surviving
mice after 14 days. The data show the percentage of mice infected with single P. aeruginosa strains analyzed in two to three independent experiments.
Statistical significance by Chi-square test is indicated: *P < 0.05, **P < 0.01, ***P < 0.001
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mice had chronic airways colonization by RP45 (80 %)
and RP73 (90 %), demonstrating the persistent lifestyle
of this lineage among surviving mice. PAO1 strain
showed less capacity to establish chronic infection
(24 %). The ability of the clinical isolate RP73 to achieve
long-term chronic infection associated with no risk of
mortality in mice was superior to all other P. aeruginosa
clinical strains tested in previous studies [17].
To assess clinical trait of chronic infection, lung histo-
pathology was performed after 14 days from P. aerugi-
nosa challenge with the persistent RP73 isolate. Chronic
pulmonary disease, including inflammation and mucus
secretory cells, was detected. The bronchi were filled by
a massive neutrophil inflammation, whereas the paren-
chyma was infiltrated by macrophages, lymphocytes and
some neutrophils (Fig. 3a). Agar beads were observed in
bronchial lumina (Fig. 3b). Mucous secretory cells
hyperplasia (Fig. 3c) was found. These features resem-
bled lesions found in CF patients with advanced chronic
pulmonary disease [18].
Genome sequences of RP isolates and comparative
genomics analyses
To link the persistent lifestyle with a genetic basis, we
sequenced the genome of RP73 [19], in addition to those
of preceding RP1 and clonal RP45 isolates, and per-
formed comparative genomic analysis. The fully
assembled RP73 genome consists of a single circular
chromosome of 6,342,034 base pairs (Additional file 3
for genome description). Twelve genomic islands were
predicted in this genome (Table 1); three of them distin-
guished RP73 from other prototype strains and corre-
sponded to regions of genome plasticity (Fig. 4) [5].
They include known genomic islands PAGI-9, which is
similar to rearrangement hot spots (Rhs) [20], and plas-
mid pKLC102, which carries the pil gene cluster and
chvB glucan synthetase [21]. Nucleotide blast search on
NCBI limited to P. aeruginosa showed that the former
can be found in multiple clinical isolates, while the latter
is identical to RP73 only in strain 8380, isolated from
the human gut. However, plasmid pKLC102 is often par-
tially present [22]. A SMC4389 CRISPR repeat sequence
also differentiates RP73 from most prototype strains [6].
In fact, blast search for this sequence resulted in a single
hit from soil strain Azotobacter chroococcum NCIMB
8003. The RP73 genome also contains full length
LESGI-4, which was identified in the Liverpool epidemic
strain (LES) [23]. Genomic islands predicted in RP73
were investigated in the draft genomes of RP1 and RP45.
While RP45 carries all 12, RP1 lacks full-length plasmid
pKLC102 and an ABC transporter protein. A circular
map comparing the 3 sequenced RP genomes clearly
shows the genomic similarity between RP45 and RP73
on one hand, and between RP1 and strain PA14, which
Fig. 3 Histological lesions after chronic P. aeruginosa infection in mice. Mice were infected with 2x106 cfu/lung of P. aeruginosa RP73 strain
embedded in agar beads and lung harvested after 14 days from challenge. Histopathological analysis of lungs chronically infected by RP73 strain
are characterised by acute and chronic lesions; the pulmonary parenchyma is infiltrated by macrophages, lymphocytes and some neutrophils (a).
Agar beads (arrow) containing bacteria macrocolonies (*) are localised in the bronchia and surrounded by a massive neutrophils inflammation (b).
Alcian blue staining shows mucus secretory cells hyperplasia (circle) (c)
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showed similar results in the murine infection model, on
the other (Fig. 4).
In order to study the evolution of chronic infection
and determine which genetic determinants are involved
in this process, further comparisons were made among
RP isolates. First, analyses were carried out to study the
relationship between these three strains. A core genome
phylogeny was performed using 53 sequences from a
previous study [24] representing an extensive sampling
of P. aeruginosa’s diversity. In the resulting tree (Fig. 5),
RP73 and RP45 cluster together while RP1 is found in a
different and independent branch. A multi-locus se-
quence typing (MLST) analysis was also performed.
RP73 and RP45 shared the same MLST profile while
RP1 showed a different one (Additional file 4). All these
analyses suggest that RP73 and RP45 are close to each
other from a genetic point of view, while RP1 is more
distantly related.
In order to explain the molecular bases of the develop-
ment of chronic infection in a CF context, SNPs were
determined between PA14 and RP1 compared to RP45
and RP73. A genomic comparison between PAO1 and
RP1 was already performed by Hilker et al. [22]. A total
of 54,621 SNPs was found by taking PA14 as reference
strain and searching for positions at which at least one
among RP1, RP45 and RP73 strains showed a different
nucleotide compared to PA14. About one fifth of these
SNPs (10,819) were non-synonymous substitutions
(Additional file 5) that are likely to have an effect on
protein function and structure. Several of these SNPs
were located in virulence genes representing good candi-
dates to explain the diversity in patterns of mortality and
chronicity we observed.
Virulence factors of RP isolates and their putative role in
pathogenicity
The genome of RP isolates contains most of the viru-
lence factors, described for other P. aeruginosa genomes
and identified in the Virulence Factor (VF) database
(http://www.mgc.ac.cn/VFs/) [25], with few exceptions.
Several VFs of RP73 isolate shows signatures of pathoa-
daptive mutations within the genome when compared to
the preceding clonal RP45 isolate as reported in
Additional files 5 and 6. Phenotypic characterization of
RP isolates is reported (Table 2) and their putative role
in pathogenicity discussed.
Table 1 Predicted genomic islands in the genome of P. aeruginosa RP73 and comparison with other RP isolates and prototype
strains














RP45 RP1 PA14 PAO1 LESB58 PA7
1–3 1023578 1126198 102620 Pseudomonas aeruginosa strain C plasmid pKLC102 41 P * * - - *
4 1372342 1385723 13381 Major facilitator transporter, 2-isopropylmalate
synthase, putative membrane-bound lytic murein
transglycolase A, hypothetical proteins
na P P P P P -
5 1408824 1421034 12210 Pseudomonas aeruginosa strain SMC4389 CRISPR
repeat sequence
12 P P - - - -
6 2576892 2587628 10736 Non-ribosomal peptide synthetases, hypothetical
proteins
na P P P P P -
7 3092401 3101220 8819 Type II secretion system proteins, ABC transporter
permease, hypothetical proteins
na P P P P P -
8 3764047 3768307 4260 Hypothetical proteins na P P P P P -
9 3818768 3828628 9860 Non-ribosomal peptide synthetase, FAD-dependent
monooxygenase, short chain dehydrogenase,
cytochrome P450, 3-oxoacyl-(acyl carrier protein)
synthase III, acyl carrier protein, major facilitator
transporter
na P P P P P -
10 4356197 4363888 7691 Pseudomonas aeruginosa PAGI-9 genomic
island sequence
89 P P - - - -
11 5866390 5877731 11341 Putative short-chain dehydrogenase, ABC
transporter ATP-binding protein,
hypothetical proteins
na P * * * * *
12 6002572 6007043 4471 Hypothetical proteins na P P - P P -
Genomic islands were predicted using Island Viewer [52] and described based on annotation with xBase [53] using P. aeruginosa PAO1 as a reference genome
Colocalization with regions of genome plasticity previously described by Klockgether et al. [5], P present, *: partially present (20–90 % coverage), -: absent
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Motility, adherence and cell interaction
Pili, flagella and outer membrane proteins promote mo-
tility, attach to epithelial or endothelial cells, activate or
inactivate host cellular pathways and immune responses
[26]. These P. aeruginosa VFs play a key role in acute in-
fection and are present in RP1 isolate. Variations in the
twitching and swimming motility are common in P. aer-
uginosa isolates from CF patients and described to be
hallmarks of bacterial adaptation to the airways [7, 27].
Both RP73 and its clonal RP45 isolate did not encode
pilV, pilW, pilY2 and fimT and carried a premature stop
mutation in pilO (Table 3); while pilA and pilC were de-
leted in all isolates from RP patient. The RP73 and RP45
phenotypes are consistent with the absence of twitching
and swimming motility (Table 2). Lack of motility was
associated with decreased virulence in models of acute
infection [28, 29] and increased risk of chronic infection
[17]. Our results obtained in RP73 and RP45-infected
mice (Fig. 2) are consistent with the observation that un-
like strains RP1, PA14 and PAO1, favor long-term
persistence.
Lipopolysaccharides (LPSs) are potent immune stimu-
lants through their interactions with Toll-like receptor 4
(TLR4). P. aeruginosa strains isolated from CF patients
evolved the capacity to reduce host immuno-detection
by modulating LPS structure [30]. Biochemical and bio-
logical characterization of RP73 LPS showed to possess
an under-acylated lipid A leading to a lower pro-
inflammatory capacity in a murine model of intranasal
instillation when compared to the LPS from the
Fig. 4 Circular map of P. aeruginosa RP isolates and prototype strain PA14. Circular map constructed with the CGView Comparison Tool [56].
Starting from the outside: genomic islands predicted with IslandViewer (see Table 1 for details) [52], RP73, RP45, RP1, PA14 and GC content.
Colored regions are shared with RP73 according to blast search. Dotted lines: known genomic islands (GIs) that distinguish RP73 because they are
incomplete or absent in the 12 complete P. aeruginosa genomes available at pseudomonas.com. RP isolates also carry LESGI-4, identified in the
Liverpool epidemic strain
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prototype strain PAO1 [31]. This structure is distin-
guished by the absence of hexa- or hepta-acylated lipid
A species that are typical phenotypic changes that can
occur on the LPS molecule of a P. aeruginosa chronic
strain. Furthermore, RP73 carries an R-type LPS without
O-antigen in which the lipid A is covalently linked to
the core oligosaccharide region. Absence of LPS O-
antigen in RP73 suggests an adaptation of this strain to
persistent lifestyle.
Among genes responsible for lipid A modification
(lpxO1, lpxO2, phoP, phoQ, pagL and oprH) [30], our
genetic characterization showed that RP73 isolate carries
a stop mutation and lacks of the C-terminus of the pro-
tein in lpxO2 compared to the preceding clonal RP45, as
well as RP1 isolate and prototype PAO1 and PA14
strains (Table 3). Both RP45 and RP73 isolates carry a
non-synonimous SNP in the sequence of pagL compared
with RP1 and PA14 (Additional files 5 and 6). These data
suggests that an adaptive process has occurred to the
LPS structure of the RP lineage in the period of time be-
tween the isolation of RP45 and RP73.
Secretion systems and toxins
In P. aeruginosa genome, the genes (psc, pcr, exs and
pop) encoding the type III secretion system (T3SS) are
clustered together. The psc and prc genes primarily en-
code components of the bacterial secretion apparatus
whereas the exs gene products are involved in regulation
of TTSS. Two pop genes encode proteins (PopB and
PopD) essential for the translocation of the effectors into
host cells. Remarkably, RP73 isolate lost the entire 32-
gene cluster encoding the T3SS which was present in
the preceding clonal RP45, as well as RP1 and prototype
PAO1 and PA14 strains (Table 3) [25]. However, the
exoS, exoT, and exoY genes encoding for the “T3SS
translocated effectors” are still present both in RP73 and
RP45 genome with two non-synonymous SNPs recorded
in the exoT when compared with RP1 and PA14 (Table 3
and Additional files 5 and 6). T3SS is an important viru-
lence determinant of P. aeruginosa which may act at the
site of infection and contribute to subversion of the host
immune response. In contrast to acute infection, small
proportion of isolates infecting CF patients secrete T3SS
proteins and this proportion decreases with duration of
infection [32]. We speculate that the differences in the
risk of mortality associated to RP73 and RP45 isolates
may be linked to absence or presence of the T3SS that
changed during the progression of CF chronic infection.
Genes encoding for toxA, hcnA, hcnB and hcnC are
present. However, RP73 has two non-synonymous SNPs
compared with its clonal isolate RP45, as well as RP1
and PA14, in hcnC gene. If we consider the exotoxin A,
we observed several non-synonymous SNPs (Table 3 and
Additional file 5).
Fig. 5 Core genome phylogeny for RP isolates and strains
representative of P. aeruginosa diversity. The figure represents a
partial view of the tree to show the relationships between RP1, RP45
and RP73. The position of RP1 is indicated in blue, while the position
of RP45 and RP73 is indicated in red. PA14 is distantly related to all
these strains











Pyocyanin # Biofilm° Antibiotic resistance
RP1 - 2.3 3.4 2.1 1.2 - 0.094 ± 0.016 0.332 ± 0.141 -
RP45 - - - - - + 0.051 ± 0.015 0.493 ± 0.146 GEN
RP73 - - - - 1.3 + 0.05 ± 0.013 1.289 ± 0.596 AMK; CAZ; GEN; IMP; MER
PAO1 - 1.2 2.6 1.8 2.0 - 0.127 ± 0.015 1.719 ± 0.217 -
PA14 - 1.2 5 2.1 2.0 - 0.09 ± 0 3.553 ± 0.457 -
*Indicates twitching and swarming motility zone diameter, as measured by subsurface stab assay
§Isolates with iridescent and metallic sheen of the colony surface, that is typical for a lasR mutant, are indicated (+)
#Indicates mean value ± SD at 26 h. Values ≤ 0.05 indicate no production of pyocyanin
°Indicates mean value ± SD at 24 h
AMK amikacin, CAZ ceftazidime, GEN gentamicin, IMP imipenem, MER meropenem
Bianconi et al. BMC Genomics  (2015) 16:1105 Page 7 of 13
Table 3 Comparative pathogenomics of mutations present in the major virulence factors of RP isolates respect to the prototype
strain PAO1 and evaluation in others P. aeruginosa sequenced strains




Type IV Pili biosynthesis pilA PA4525 PA14_58730 PLES_49071 PSPA7_5161 deleted3 deleted3 deleted
pilC PA4527 PA14_58760 PLES_49101 PSPA7_5163 deleted3 deleted3 deleted




pilV PA4551 deleted PLES_49341 PSPA7_5191 present deleted4 deleted
pilW PA4552 PA14_60290 PLES_49351 PSPA7_5192 present deleted4 deleted
pilY2 PA4555 deleted PLES_49381 PSPA7_5195 present deleted4 deleted
fimT PA4549 deleted PLES_49321 PSPA7_5189 present deleted3 deleted
Alginate regulation algP/algR3 PA5253 PA14_69370 PLES_56471 PSPA7_5998 present present present




Pyoverdin pvdD PA2399 PA14_33650 PLES_28971 deleted present5 present present stop codon
after 839 aa










pscQ PA1694 PA14_42610 PLES_36321 deleted present present deleted
pscP PA1695 PA14_42600 deleted deleted present present5 deleted
pscO PA1696 PA14_42580 PLES_36311 deleted present present deleted
pscN PA1697 PA14_42570 PLES_36301 deleted present present deleted
poPN PA1698 PA14_42550 PLES_36291 deleted present present deleted
pcr1 PA1699 PA14_42540 PLES_36281 deleted present present deleted
pcr2 PA1700 PA14_42530 PLES_36271 deleted present present deleted
pcr3 PA1701 PA14_42520 PLES_36261 deleted present present deleted
pcr4 PA1702 PA14_42510 PLES_36251 deleted present present deleted
pcrD PA1703 PA14_42500 PLES_36241 deleted present present deleted
pcrR PA1704 PA14_42490 PLES_36231 deleted present present deleted
pcrG PA1705 PA14_42480 PLES_36221 deleted present present deleted
pcrV PA1706 PA14_42470 PLES_36211 deleted present present deleted
pcrH PA1707 PA14_42460 deleted deleted present present deleted
poPB PA1708 PA14_42450 PLES_36201 deleted present present deleted
poPD PA1709 PA14_42440 PLES_36191 deleted present present deleted
exsC PA1710 PA14_42430 PLES_36181 deleted present present deleted
exsE PA1711 PA14_42410 deleted deleted present present deleted
exsB PA1712 PA14_42400 PLES_36171 deleted present present deleted
exsA PA1713 PA14_42390 PLES_36161 deleted present present deleted
exsD PA1714 PA14_42380 PLES_36151 deleted present present deleted
pscB PA1715 PA14_42360 PLES_36141 deleted present present deleted
pscC PA1716 PA14_42350 PLES_36131 deleted present present deleted
pscD PA1717 PA14_42340 PLES_36121 deleted present5 present deleted
pscE PA1718 PA14_42320 PLES_36111 deleted present present deleted
pscF PA1719 PA14_42310 PLES_36101 deleted present present deleted
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Finally, pldA coding for the periplasmic phospholipase
D (Table 3), one of effectors of the type VI secretion sys-
tem [33], is absent in RP73 genome. However pldA is re-
ported to be not conserved among P. aeruginosa
genomes [34].
Iron uptake and pigment
The ability to produce siderophores, like pyochelin and
pyoverdine, has been linked to the bacterial pathogenic
potential. Phenotypic assay showed that RP isolates se-
creted lower (RP73 and RP1) or no (RP45) levels of side-
rophores when compared to PAO1 and PA14 (Table 2).
When we look at the genome sequence, both RP73 and
RP45 carries stop mutations both in pchD, while PvdD
protein is interrupted in RP73 only. PchD and PvdD are
both involved in the synthesis of the two principal side-
rophores (Table 3). PvdD production was shown to be
required for airways bacterial colonization in rat, lethal
virulence in burned and immunosuppressed mouse
models [35, 36]. Pyoverdine was detected in the sputa of
CF patients [37], while in a larger study, one-third of
sputa positive for P. aeruginosa contained no detectable
pyoverdine [38]. These data suggests that pyoverdine-
mediated iron uptake may not always be essential for
chronic infection and other mechanisms are active in
CF [39].
Phenotypic tests showed that RP73 and RP45 are able
to secrete less pyocyanin when compared to RP1, PAO1
and PA14 strains (Table 2). No changes in genes in-
volved in pyocyanin biosynthesis were found, however in
RP73 and RP45 were found non-synonymous SNPs in
several genes belonging to the two phenazine biosynthesis
operons (phzA1B1C1D1E1F1G1 and phzA2B2C2-
D2E2F2G2) if compared with the non-clonal isolate RP1
and the prototype strain PA14 (Additional file 5). Pyocya-
nin is required for full virulence in animal models and has
been detected in patients’ airway secretions, promoting
virulence by interfering with several cellular functions in
host cells including electron transport, cellular respiration,
energy metabolism, gene expression, and innate immune
mechanisms [40].
Mucoidy
RP isolates are phenotypically non-mucoid (Table 2) with
absence of mutations in mucABD locus. Other key regula-
tors of alginate pathway are present (Table 3). The pheno-
typic switch to mucoidy in P. aeruginosa infections is a
well-established paradigm in CF. Infection with the mucoid
phenotype, which produces large amounts of the exopoly-
saccharide alginate, has been associated with a more rapid
decline in pulmonary function than infection with non-
mucoid bacteria [41]. However, some but not all P. aerugi-
nosa isolates became mucoid in the CF lung suggesting that
a mucoid phenotype did not always confer a selective ad-
vantage to bacterial cells in persistence [42]. In mouse
model, CF clonal strains, displaying a mucoid and a non-
mucoid phenotype, showed a similar capacity of persistence
[17]. Our data obtained in mouse model with RP73 and
RP45 isolates support the notion that non-mucoid P. aeru-
ginosa strains are able of long-term persistence.
Quorum sensing
In P. aeruginosa, many virulence determinants and sec-
ondary metabolites are regulated in a cell population
Table 3 Comparative pathogenomics of mutations present in the major virulence factors of RP isolates respect to the prototype
strain PAO1 and evaluation in others P. aeruginosa sequenced strains (Continued)
pscG PA1720 PA14_42300 PLES_36091 deleted present present deleted
pscH PA1721 PA14_42290 PLES_36081 deleted present present deleted
pscI PA1722 PA14_42280 PLES_36071 deleted present present deleted
pscJ PA1723 PA14_42270 PLES_36061 deleted present present deleted
pscK PA1724 PA14_42260 PLES_36051 deleted present present deleted
pscL PA1725 PA14_42250 PLES_36041 deleted present present deleted
LPS lpxO2 PA0936 PA14_52150 PLES_43801 PSPA7_4774 present present present stop codon
after 145 aa
Efflux pumps mexA PA0425 PA14_05530 PLES_04231 PSPA7_0525 present present +29 aa at
N-ter
present +29 aa at
N-ter




Antibiotic resistance arr PA2818 deleted deleted PSPA7_2339 deleted3 deleted3 deleted
1Sources for PAO1, PA14, LESB58 and PA7 information are the Virulence Factor Database
(http://www.mgc.ac.cn/VFs/) and Pseudomonas Database (www.pseudomonas.com)
2Identified by local blast (>90 % query coverage, >90 % sequence similarity) using the PAO1 gene sequences as query
3Presence of at least one flanking region (500 bp) confirmed by blast search on contigs; gene not located at contig edge
4Flanking regions not found, but absence of the gene is consistent with a deletion in isolate RP73
5Gene is present, but separated onto multiple contigs
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density-dependent manner via cell-to-cell communica-
tion or “quorum sensing” (QS) [43]. P. aeruginosa pos-
sesses two N-acylhomoserine lactone (AHL)-dependent
QS systems. These are termed the las and rhl systems,
consisting of the LuxRI homologues, LasRI and RhlRI,
respectively. RP isolates have no mutations in lasI, rhlR
and rhlI genes. However, inactivation of the transcrip-
tional regulator LasR, carrying a stop mutation in the
gene sequence (Table 3), was found both in RP73 and
RP45, while the RP1 has no changes. The distinctive
lasR mutant phenotype was confirmed by colony
morphology that includes surface iridescent sheen and
colony flattening exclusively in RP73 and RP45
(Table 2) [44].
Mutations in lasR lead to several phenotypic changes
of potential clinical significance, including a growth ad-
vantage in amino acid abundant CF airway secretions.
LasR regulates the production of virulence factors (elas-
tase, protease, alkaline protease and exotoxin A) affect-
ing the immune response and antibiotic resistance [45].
Most importantly, lasR mutations are often associated
with the progression of CF lung disease and may serve
as a marker of early CF adaptive change of prognostic
significance [46].
Antibiotic resistance
RP73 showed remarkable resistance to most of the anti-
biotic classes while the preceding RP45 and RP1 isolates
were not, indicating an increased treatment-refractory
during the course of the chronic infection in this CF pa-
tient (Table 2). A strong link between antibiotic resist-
ance and hypermutation was observed in patients with
CF [47]. However, RP73 strain does not have mutations
in mutS, mutL and uvrD, described previously as re-
sponsible for the hypermutable phenotype [48]. Regard-
ing efflux pumps, the RP73 strain did not show
mutation in mexEF-oprN, mexCD-oprJ and mexXY. Re-
spectively one and six non-synonymous SNPs are
present in the sequence of mexC and mexD of RP73
when compared with its clonal isolate RP45. No inser-
tions or deletions in ampC, ampR, mexR, mexZ and
oprD were detected. An insertion at the N-terminal of
MexA and a non-synonymous SNP was found in RP73
and RP45 (Table 3 and Additional file 5). MexA belongs
to the efflux pump complex MexAB-OprM, which is an-
chored to the inner membrane via N-terminal fatty
acids. Adaptive mutations in mexA have been reported
in CF isolates [7].
Additional modifications were detected at the N-
terminal of mexT, which is not conserved in RP73 and
RP45 (Table 3). An additional non-synonymous aa
change at position 128 was found in RP73 when com-
pared to RP45 (Additional file 5). MexT plays a pleio-
tropic role in modulating P. aeruginosa virulence such
as TTSS, pyocyanin production and early surface attach-
ment [49]. Similarly to MexA, also MexT is an hallmark
of P. aeruginosa adaptation in CF patients [7]. Among
the additional 58 PAO1 coding sequence annotated as
“antibiotic resistance and susceptibility”, only arr, a puta-
tive aminoglycoside response regulator, is absent in all
strains from RP patient.
Conclusions
Taken together, our study combined clinical data, whole-
genome analysis and animal models to link the persist-
ent lifestyle of P. aeruginosa in CF lungs with the bacter-
ial genetic basis. Starting from a clinical case of CF, P.
aeruginosa RP73 was isolated after long-term chronic in-
fection and compared with the preceding RP1 and clonal
RP45, as well as prototype PAO1 and PA14 strains.
When tested in the animal model, P. aeruginosa RP73
isolate, but not other strains, mimics most of the traits
of airways infection and inflammation observed in CF
patients. These results suggested that key features of
RP73 isolate may contribute to its pathogenesis. The
genome sequence of RP73 and comparative genomics
analysis with other P. aeruginosa genomes, pointed
clearly to signatures of pathoadaptive mutations within
the genome. This in turn correlated with the major im-
pact on the in vitro phenotypes and in vivo maintenance
observed and described here. Our findings support and
better define the hypothesis that genes encoding major
virulence factors are deleted and/or contain beneficial
mutations when P. aeruginosa establishes long-term
chronic infection. The results presented in this study
provide important information with respect to the P.
aeruginosa mosaic genome structure and chronic infec-
tions found in CF patients.
Methods
Ethics statement
Animal studies adhered strictly to the Italian Ministry of
Health guidelines for the use and care of experimental
animals. The use of the clinical data is in line with study
no. 3739 which has been approved by the Ethics Com-
mission of Hannover Medical School. The patient and
her parents provided informed consent prior to sampling
of strains and storage of clinical data.
Bacterial strains and CF patient
CF clinical P. aeruginosa RP1, RP45 and RP73 isolates
were chosen from the collection of the CF clinic
Medizinische Hochschule Hannover, Germany. Geno-
typic analysis by multimarker array and phenotypic
data of P. aeruginosa strains were partly published
[50]. P. aeruginosa was cultured in Pseudomonas iso-
lation agar (PIA) or Trypticase Soy Broth (TSB) at
37 °C. CF patient gave informed consent before the
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sample collection. Approval for storing of biological
materials was obtained by the Hannover Medical
School, Germany.
Phenotypic characterization
Swimming and twitching capacities, protease, sidero-
phore and pyocyanin secretion, hemolytic activity, and
LasR mutant phenotypic analysis were assayed as de-
scribed in the online data supplement.
Genome sequencing
The genome of RP73 was previously published [19].
Genomic DNA from strains RP1 and RP45 was isolated
from overnight cultures using the DNeasy Blood and
Tissue Kit (QIAGEN). Genomic DNA (500 ng) was
mechanically fragmented for 40 s using a Covaris M220
(Covaris, Woburn MA, USA) with default settings. Frag-
mented DNA was transferred to PCR tubes and library
synthesis was performed with the Kapa Hyperprep kit
(Kapa biosystems, Wilmington MA, USA) according to
manufacturer’s instructions. TruSeq HT adapters (Illu-
mina, SanDiego, CA, USA) were used to barcode the
samples and each library was sequenced in 1/48 of an
Illumina MiSeq 300 bp paired-end run at the Plateforme
d’Analyses Génomiques of the Institut de Biologie In-
tégrative et des Systèmes (Laval University, Quebec,
Canada). Sequencing data for each genome was as-
sembled with the A5 pipeline [51]. Whole genome
shotgun projects has been deposited at DDBJ/EMBL/
GenBank under accessions LNBU00000000 (RP1) and
LNDM00000000 (RP45).
Genomic analyses
Blast (NCBI) was used to compare the genome of RP73
to prototype strains and to the complete Pseudomonas
aeruginosa content in Genbank. Genomic islands were
predicted with Island Viewer [52] and annotated with
xBase [53]. The core genome phylogeny was determined
using the Harvest suite [51]. The data set of sequences
we used to generate the core phylogeny includes 53
strains representative of P. aeruginosa diversity. MLST
profiles were determined combining the results obtained
from the pubmlst database (http://pubmlst.org) and the
SRST2 software package [54]. SNPs between PA14 and
RP1, RP45 and RP73 were detected with the Samtools
software package [55] (samtools mpileup options: -C 50,
SNPs with quality score of less than 30 were discarded).
Mouse model of P. aeruginosa acute and chronic lung
infection
For chronic infection, C57BL/6NCrlBR male mice
(20–22 g, Charles River) were infected with 1-2×106
CFUs of P. aeruginosa strains, embedded in agar
beads [15, 17]. Fourteen days post-challenge lungs
were recovered, homogenized and plated for CFUs
counting. In additional group of mice, the lungs were
excised for histopathology. Additional details are re-
ported in the Online data supplement. Student’s t-test
and the χ2 test considering p < 0.05 as the limit of
statistical significance was performed.
Availability of supporting data
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